Clinical Respiratory Medicine
51 – 60 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
Dual bronchodilator therapy as first-line treatment in maintenance-naïve patients with symptomatic copd : A pre-specified analysis of the emax trial
(
- Contribution to journal › Article
- 2020
-
Mark
A new role for “eat me” and “don’t eat me” markers on neutrophils in asthmatic airway inflammation
(
- Contribution to journal › Letter
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
-
Mark
Nordstar : Paving the way for a new era in asthma research
(
- Contribution to journal › Article
-
Mark
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD : a post hoc analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity : Common molecular pathways in Covid-19 and pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Salbutamol use in relation to maintenance bronchodilator efficacy in COPD : a prospective subgroup analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter